Apyx Medical (APYX) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

APYX Stock Forecast

Apyx Medical stock forecast is as follows: an average price target of $8.50 (represents a 574.60% upside from APYX’s last price of $1.26) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

APYX Price Target

The average price target for Apyx Medical (APYX) is $8.50 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $12.00 to $5.00. This represents a potential 574.60% upside from APYX's last price of $1.26.

APYX Analyst Ratings

Buy

According to 3 Wall Street analysts, Apyx Medical's rating consensus is 'Buy'. The analyst rating breakdown for APYX stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Apyx Medical Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Dec 08, 2022	-	Lake Street	$5.00	$1.85	170.27%	296.83%
Aug 11, 2022	Matt O'Brien	Piper Sandler	$12.00	$10.28	16.73%	852.38%
Jul 19, 2022	-	Lake Street	$17.00	$8.44	101.54%	1249.21%

Row per page

Go to

The latest Apyx Medical stock forecast, released on Dec 08, 2022 by Lake Street company, set a price target of $5.00, which represents a 170.27% increase from the stock price at the time of the forecast ($1.85), and a 296.83% increase from APYX last price ($1.26).

Apyx Medical Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	-
Avg Price Target	-	-	-
Last Closing Price	$1.26	$1.26	$1.26
Upside/Downside	-100.00%	-100.00%	-100.00%

In the current month, the average price target of Apyx Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Apyx Medical's last price of $1.26. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 16, 2024	BTIG	-	Neutral	Initialise
Aug 11, 2022	Piper Sandler	Overweight	Overweight	Hold
Jul 19, 2022	Lake Street	Buy	Buy	Hold

Row per page

Go to

Apyx Medical's last stock rating was published by BTIG on Oct 16, 2024. The company Initialise its APYX rating from "null" to "Neutral".

Apyx Medical Financial Forecast

Apyx Medical Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$14.66M	$15.97M	$17.86M	$12.14M	$12.61M	$9.11M	$10.29M	$12.49M	$16.82M	$11.83M	$11.22M	$8.64M	$11.46M	$6.95M	$4.30M	$5.00M	$8.46M	$7.58M
Avg Forecast	$14.83M	$12.83M	$13.27M	$10.71M	$14.88M	$11.98M	$12.48M	$10.28M	$14.49M	$11.38M	$11.75M	$9.53M	$14.85M	$15.37M	$14.33M	$10.84M	$12.94M	$12.01M	$10.56M	$11.12M	$14.63M	$10.20M	$8.86M	$7.84M	$10.27M	$5.69M	$1.97M	$5.20M	$7.86M	$6.78M
High Forecast	$14.99M	$12.96M	$13.41M	$10.82M	$15.03M	$12.10M	$12.61M	$10.38M	$14.64M	$11.57M	$11.75M	$9.53M	$15.01M	$15.37M	$14.47M	$10.95M	$13.07M	$12.01M	$10.56M	$11.12M	$14.63M	$10.20M	$8.86M	$7.84M	$10.27M	$5.69M	$1.97M	$5.20M	$7.86M	$6.78M
Low Forecast	$14.72M	$12.73M	$13.17M	$10.63M	$14.77M	$11.89M	$12.38M	$10.20M	$14.38M	$11.19M	$11.75M	$9.53M	$14.74M	$15.37M	$14.22M	$10.75M	$12.84M	$12.01M	$10.56M	$11.12M	$14.63M	$10.20M	$8.86M	$7.84M	$10.27M	$5.69M	$1.97M	$5.20M	$7.86M	$6.78M
# Analysts	1	1	1	1	1	1	1	2	2	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	13	7	7	9	8	6
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.99%	1.04%	1.25%	1.12%	0.97%	0.76%	0.97%	1.12%	1.15%	1.16%	1.27%	1.10%	1.12%	1.22%	2.19%	0.96%	1.08%	1.12%

Apyx Medical's average Quarter revenue forecast for Mar 24 based on 1 analysts is $9.53M, with a low forecast of $9.53M, and a high forecast of $9.53M. APYX's average Quarter revenue forecast represents a -35.02% decrease compared to the company's last Quarter revenue of $14.66M (Dec 23).

Apyx Medical EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	2	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	13	7	7	9	8	6
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-5.62M	$-4.64M	$-1.24M	$-5.57M	$-5.91M	$-5.53M	$-5.10M	$-5.67M	$-1.64M	$-3.91M	$-3.72M	$-4.60M	$-1.69M	$-4.20M	$-5.95M	$-6.64M	$-5.81M	$-3.62M
Avg Forecast	$-7.33M	$-6.34M	$-6.56M	$-5.29M	$-7.35M	$-5.92M	$-6.17M	$-5.08M	$-7.16M	$-5.62M	$-5.81M	$-4.71M	$-7.34M	$-7.60M	$-7.08M	$-5.36M	$-6.39M	$-6.23M	$-5.48M	$-4.89M	$-7.59M	$-5.29M	$-4.60M	$-4.60M	$-5.32M	$-2.95M	$-1.02M	$-10.51M	$-4.08M	$-3.52M
High Forecast	$-7.28M	$-6.29M	$-6.51M	$-5.25M	$-7.30M	$-5.88M	$-6.12M	$-5.04M	$-7.11M	$-5.53M	$-5.81M	$-4.71M	$-7.29M	$-7.60M	$-7.03M	$-5.31M	$-6.34M	$-6.23M	$-5.48M	$-3.91M	$-7.59M	$-5.29M	$-4.60M	$-3.68M	$-5.32M	$-2.95M	$-1.02M	$-8.41M	$-4.08M	$-3.52M
Low Forecast	$-7.41M	$-6.41M	$-6.63M	$-5.35M	$-7.43M	$-5.98M	$-6.23M	$-5.13M	$-7.24M	$-5.72M	$-5.81M	$-4.71M	$-7.42M	$-7.60M	$-7.15M	$-5.41M	$-6.46M	$-6.23M	$-5.48M	$-5.87M	$-7.59M	$-5.29M	$-4.60M	$-5.52M	$-5.32M	$-2.95M	$-1.02M	$-12.61M	$-4.08M	$-3.52M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.77%	0.61%	0.17%	1.04%	0.92%	0.89%	0.93%	1.16%	0.22%	0.74%	0.81%	1.00%	0.32%	1.42%	5.84%	0.63%	1.43%	1.03%

undefined analysts predict APYX's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Apyx Medical's previous annual EBITDA (undefined) of $NaN.

Apyx Medical Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	2	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	13	7	7	9	8	6
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-9.61M	$-4.63M	$-994.00K	$-3.53M	$-6.07M	$-5.79M	$-5.45M	$-5.97M	$-2.01M	$-4.22M	$-4.05M	$-4.90M	$-1.53M	$-3.73M	$-4.69M	$-1.95M	$-5.81M	$-4.31M
Avg Forecast	$-2.99M	$-3.82M	$-3.65M	$-4.78M	$-4.07M	$-3.90M	$-3.90M	$-4.16M	$-4.78M	$-6.37M	$-6.86M	$-7.48M	$-6.17M	$-3.95M	$-2.43M	$-4.68M	$-4.94M	$-5.02M	$-6.50M	$-5.15M	$-3.81M	$-5.20M	$-5.11M	$-4.90M	$-3.72M	$-5.72M	$-7.36M	$-3.09M	$-6.67M	$-6.24M
High Forecast	$-2.96M	$-3.78M	$-3.62M	$-4.73M	$-4.03M	$-3.86M	$-3.86M	$-4.12M	$-4.73M	$-6.31M	$-6.79M	$-7.41M	$-5.22M	$-3.91M	$-2.40M	$-4.63M	$-4.89M	$-5.02M	$-6.50M	$-4.12M	$-3.81M	$-5.20M	$-5.11M	$-3.92M	$-3.72M	$-5.72M	$-7.36M	$-2.47M	$-6.67M	$-6.24M
Low Forecast	$-3.03M	$-3.87M	$-3.70M	$-4.84M	$-4.13M	$-3.95M	$-3.95M	$-4.21M	$-4.84M	$-6.46M	$-6.95M	$-7.58M	$-7.12M	$-4.00M	$-2.46M	$-4.74M	$-5.00M	$-5.02M	$-6.50M	$-6.18M	$-3.81M	$-5.20M	$-5.11M	$-5.88M	$-3.72M	$-5.72M	$-7.36M	$-3.71M	$-6.67M	$-6.24M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.56%	1.17%	0.41%	0.76%	1.23%	1.15%	0.84%	1.16%	0.53%	0.81%	0.79%	1.00%	0.41%	0.65%	0.64%	0.63%	0.87%	0.69%

Apyx Medical's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. APYX's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Apyx Medical SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	2	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	13	7	7	9	8	6
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$8.59M	$4.84M	$5.38M	$12.06M	$12.92M	$10.48M	$11.82M	$12.93M	$12.90M	$10.85M	$10.49M	$9.49M	$8.84M	$8.05M	$7.29M	$9.50M	$10.92M	$8.78M
Avg Forecast	$14.96M	$12.94M	$13.39M	$10.80M	$15.01M	$12.08M	$12.58M	$10.36M	$14.62M	$11.48M	$11.86M	$9.61M	$14.98M	$15.50M	$14.45M	$10.93M	$13.05M	$12.11M	$10.65M	$11.22M	$14.75M	$10.28M	$8.94M	$7.91M	$10.35M	$5.74M	$1.98M	$5.25M	$7.92M	$6.84M
High Forecast	$15.11M	$13.07M	$13.52M	$10.91M	$15.16M	$12.21M	$12.71M	$10.47M	$14.77M	$11.67M	$11.86M	$9.61M	$15.14M	$15.50M	$14.60M	$11.04M	$13.18M	$12.11M	$10.65M	$11.22M	$14.75M	$10.28M	$8.94M	$7.91M	$10.35M	$5.74M	$1.98M	$5.25M	$7.92M	$6.84M
Low Forecast	$14.85M	$12.84M	$13.28M	$10.72M	$14.89M	$11.99M	$12.49M	$10.29M	$14.51M	$11.28M	$11.86M	$9.61M	$14.87M	$15.50M	$14.34M	$10.85M	$12.95M	$12.11M	$10.65M	$11.22M	$14.75M	$10.28M	$8.94M	$7.91M	$10.35M	$5.74M	$1.98M	$5.25M	$7.92M	$6.84M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.57%	0.31%	0.37%	1.10%	0.99%	0.86%	1.11%	1.15%	0.87%	1.05%	1.17%	1.20%	0.85%	1.40%	3.68%	1.81%	1.38%	1.28%

Apyx Medical's average Quarter SG&A projection for Mar 24 is $9.61M, based on 1 Wall Street analysts, with a range of $9.61M to $9.61M. The forecast indicates a 11.86% rise compared to APYX last annual SG&A of $8.59M (Dec 23).

Apyx Medical EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	2	1	1	1	3	1	1	1	1	1	1	1	1	1	1	1	13	7	7	9	8	6
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.28	$-0.13	$-0.03	$-0.10	$-0.18	$-0.17	$-0.16	$-0.17	$-0.06	$-0.12	$-0.12	$-0.14	$-0.04	$-0.11	$-0.14	$-0.06	$-0.16	$-0.13
Avg Forecast	$-0.09	$-0.11	$-0.11	$-0.14	$-0.12	$-0.11	$-0.11	$-0.12	$-0.14	$-0.18	$-0.20	$-0.22	$-0.18	$-0.11	$-0.07	$-0.14	$-0.14	$-0.14	$-0.19	$-0.15	$-0.11	$-0.15	$-0.15	$-0.14	$-0.11	$-0.17	$-0.21	$-0.25	$-0.19	$-0.18
High Forecast	$-0.09	$-0.11	$-0.10	$-0.14	$-0.12	$-0.11	$-0.11	$-0.12	$-0.14	$-0.18	$-0.20	$-0.21	$-0.15	$-0.11	$-0.07	$-0.13	$-0.14	$-0.14	$-0.19	$-0.15	$-0.11	$-0.15	$-0.15	$-0.14	$-0.11	$-0.17	$-0.21	$-0.25	$-0.19	$-0.18
Low Forecast	$-0.09	$-0.11	$-0.11	$-0.14	$-0.12	$-0.11	$-0.11	$-0.12	$-0.14	$-0.19	$-0.20	$-0.22	$-0.21	$-0.12	$-0.07	$-0.14	$-0.14	$-0.14	$-0.19	$-0.15	$-0.11	$-0.15	$-0.15	$-0.14	$-0.11	$-0.17	$-0.21	$-0.25	$-0.19	$-0.18
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.57%	1.14%	0.43%	0.74%	1.26%	1.17%	0.85%	1.16%	0.53%	0.80%	0.81%	0.97%	0.37%	0.67%	0.66%	0.24%	0.83%	0.72%

According to undefined Wall Street analysts, Apyx Medical's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to APYX previous annual EPS of $NaN (undefined).

Apyx Medical Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
APYX	Apyx Medical	$1.26	$8.50	574.60%	Buy
INGN	Inogen	$10.05	$26.00	158.71%	Buy
SGHT	Sight Sciences	$3.80	$9.00	136.84%	Hold
LUNG	Pulmonx	$6.34	$11.93	88.17%	Buy
KIDS	OrthoPediatrics	$22.93	$39.60	72.70%	Buy
NPCE	NeuroPace	$8.98	$12.88	43.43%	Buy
LIVN	LivaNova	$52.10	$70.50	35.32%	Buy
OFIX	Orthofix Medical	$18.08	$24.00	32.74%	-
AVNS	Avanos Medical	$18.68	$23.00	23.13%	Hold
AORT	Artivion	$26.65	$30.60	14.82%	Buy
SRDX	Surmodics	$38.72	$39.50	2.01%	Buy

APYX Forecast FAQ

Is Apyx Medical a good buy?

Yes, according to 3 Wall Street analysts, Apyx Medical (APYX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of APYX's total ratings.

What is APYX's price target?

Apyx Medical (APYX) average price target is $8.5 with a range of $5 to $12, implying a 574.60% from its last price of $1.26. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Apyx Medical stock go up soon?

According to Wall Street analysts' prediction for APYX stock, the company can go up by 574.60% (from the last price of $1.26 to the average price target of $8.5), up by 852.38% based on the highest stock price target, and up by 296.83% based on the lowest stock price target.

Can Apyx Medical stock reach $2?

APYX's average twelve months analyst stock price target of $8.5 supports the claim that Apyx Medical can reach $2 in the near future.

What are Apyx Medical's analysts' financial forecasts?

Apyx Medical's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $49.61M (high $50.12M, low $49.23M), average EBITDA is $-24.521M (high $-24.334M, low $-24.773M), average net income is $-16.023M (high $-15.863M, low $-16.237M), average SG&A $50.04M (high $50.55M, low $49.66M), and average EPS is $-0.462 (high $-0.458, low $-0.469). APYX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $51.64M (high $52.17M, low $51.25M), average EBITDA is $-25.524M (high $-25.329M, low $-25.786M), average net income is $-15.24M (high $-15.089M, low $-15.443M), average SG&A $52.09M (high $52.62M, low $51.69M), and average EPS is $-0.44 (high $-0.436, low $-0.446).

Did the APYX's actual financial results beat the analysts' financial forecasts?

Based on Apyx Medical's last annual report (Dec 2023), the company's revenue was $52.35M, which missed the average analysts forecast of $55.38M by -5.48%. Apple's EBITDA was $-19.259M, missing the average prediction of $-27.374M by -29.65%. The company's net income was $-18.713M, beating the average estimation of $-17.218M by 8.68%. Apple's SG&A was $29.23M, missing the average forecast of $55.86M by -47.68%. Lastly, the company's EPS was $-0.54, beating the average prediction of $-0.497 by 8.65%. In terms of the last quarterly report (Dec 2023), Apyx Medical's revenue was $14.66M, missing the average analysts' forecast of $14.85M by -1.29%. The company's EBITDA was $-5.624M, missing the average prediction of $-7.341M by -23.39%. Apyx Medical's net income was $-9.607M, beating the average estimation of $-6.167M by 55.79%. The company's SG&A was $8.59M, missing the average forecast of $14.98M by -42.66%. Lastly, the company's EPS was $-0.28, beating the average prediction of $-0.178 by 57.30%